| Literature DB >> 31957987 |
Hasan Bas1, Oguz Cilingir1, Neslihan Tekin2, Suzan Saylisoy3, Beyhan Durak Aras1, Elif Uzay1, Ebru Erzurumluoglu Gokalp1, Sevilhan Artan1.
Abstract
S-adenosylhomocysteine hydrolase deficiency is an autosomal recessive neurometabolic disorder affecting the muscles, liver, and nervous system. The disease occurs by pathogenic variants of AHCY gene encoding S-adenosylhomocysteine hydrolase (AHCY) enzyme. This article reports a patient with presumed AHCY deficiency who was diagnosed by whole exome sequencing due to compound heterozygosity of novel p.T57I (c.170C>T) and p.V217M (c.649G>A) variants of AHCY gene. The patient had diffuse edema, coagulopathy, central nervous system abnormalities, and hypotonia. She died in 3 months due to cardiovascular collapse. Clinical findings of the present case were compatible with previously reported AHCY deficiency patients and the novel variants we found are considered to be the cause of the symptoms. This article also compiles the previous reports and expands clinical spectrum of AHCY deficiency by adding new features.Entities:
Keywords: AHCY; S-adenosylhomocysteine hydrolase deficiency; WES; metabolic disorders
Mesh:
Substances:
Year: 2020 PMID: 31957987 DOI: 10.1002/ajmg.a.61489
Source DB: PubMed Journal: Am J Med Genet A ISSN: 1552-4825 Impact factor: 2.802